Ayano Kabashima

791 total citations
16 papers, 625 citations indexed

About

Ayano Kabashima is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ayano Kabashima has authored 16 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 5 papers in Immunology. Recurrent topics in Ayano Kabashima's work include Cancer Cells and Metastasis (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Extracellular vesicles in disease (2 papers). Ayano Kabashima is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Pancreatic and Hepatic Oncology Research (3 papers) and Extracellular vesicles in disease (2 papers). Ayano Kabashima collaborates with scholars based in Japan, United States and Czechia. Ayano Kabashima's co-authors include Petra Hirsova, Hajime Higuchi, Motoko Izumiya, Toshifumi Hibi∥, Samar H. Ibrahim, Hiromasa Takaishi, Gen Sakai, Toshifumi Azuma, Shigenari Hozawa and Kunimaro Furuta and has published in prestigious journals such as Gastroenterology, Scientific Reports and Journal of Hepatology.

In The Last Decade

Ayano Kabashima

16 papers receiving 623 citations

Peers

Ayano Kabashima

ONCOL

EPIDE

IMMUN

Karl Quint Germany

Chencheng Xie United States

Avijit Majumdar United States

Haiyuan Shen China

Chunyang Xing China

Kostas Evangelou Greece

Tze‐Sian Chan Taiwan

Changku Jia China

Shuang-Jian Qiu China

Karl Quint Germany

Ayano Kabashima

457 ×1.2

213 ×1.0

ONCOL

159 ×1.0

146 ×1.4

EPIDE

53 ×0.5

IMMUN

Citations per year, relative to Ayano Kabashima Ayano Kabashima (= 1×) peers Karl Quint

Countries citing papers authored by Ayano Kabashima

Since Specialization

Citations

This map shows the geographic impact of Ayano Kabashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayano Kabashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayano Kabashima more than expected).

Fields of papers citing papers by Ayano Kabashima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayano Kabashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayano Kabashima. The network helps show where Ayano Kabashima may publish in the future.

Co-authorship network of co-authors of Ayano Kabashima

This figure shows the co-authorship network connecting the top 25 collaborators of Ayano Kabashima. A scholar is included among the top collaborators of Ayano Kabashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayano Kabashima. Ayano Kabashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Shimada, Shu, Yoshimitsu Akiyama, Ayano Kabashima, et al.. (2023). RTP4 silencing provokes tumor-intrinsic resistance to immune checkpoint blockade in colorectal cancer. Journal of Gastroenterology. 58(6). 540–553. 5 indexed citations

Kabashima, Ayano, Saki Ito, Yoshimitsu Akiyama, et al.. (2022). cGAS-STING signaling encourages immune cell overcoming of fibroblast barricades in pancreatic cancer. Scientific Reports. 12(1). 10466–10466. 28 indexed citations

Ishii, Takeshi, Yoshimitsu Akiyama, Shu Shimada, et al.. (2022). Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer. Cancer Science. 114(2). 463–476. 9 indexed citations

Shimada, Shu, Ayano Kabashima, Yoshimitsu Akiyama, et al.. (2021). Intrinsic activation of β-catenin signaling by CRISPR/Cas9-mediated exon skipping contributes to immune evasion in hepatocellular carcinoma. Scientific Reports. 11(1). 16732–16732. 23 indexed citations

Buckarma, EeeLN H., Nathan W. Werneburg, Caitlin B. Conboy, et al.. (2020). The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Coactivity and Modulate Sensitivity to Chemotherapy in Cholangiocarcinoma. Molecular Cancer Research. 18(10). 1574–1588. 20 indexed citations

Kabashima, Ayano, Shu Shimada, Masahiro Shimokawa, et al.. (2020). Molecular and immunological paradigms of hepatocellular carcinoma: Special reference to therapeutic approaches. Journal of Hepato-Biliary-Pancreatic Sciences. 28(1). 62–75. 9 indexed citations

Guo, Qianqian, Kunimaro Furuta, Fabrice Lucien, et al.. (2019). Integrin β1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH. Journal of Hepatology. 71(6). 1193–1205. 141 indexed citations

Furuta, Kunimaro, Qianqian Guo, Luz Helena Gutierrez Sanchez, et al.. (2019). 494 – Extracellular Vesicles-Bearing Integrin β1 Mediate Monocytes Adhesion and Promote Liver Inflammation in Murine NASH. Gastroenterology. 156(6). S–1199. 1 indexed citations

Sugihara, Takaaki, Nathan W. Werneburg, Matthew C. Hernandez, et al.. (2018). YAP Tyrosine Phosphorylation and Nuclear Localization in Cholangiocarcinoma Cells Are Regulated by LCK and Independent of LATS Activity. Molecular Cancer Research. 16(10). 1556–1567. 84 indexed citations

10.

Kabashima, Ayano, Petra Hirsova, Steven F. Bronk, et al.. (2018). Fibroblast growth factor receptor inhibition induces loss of matrix MCL1 and necrosis in cholangiocarcinoma. Journal of Hepatology. 68(6). 1228–1238. 19 indexed citations

11.

Kinoshita, Takeshi, Hajime Higuchi, Ayano Kabashima, et al.. (2017). Analysis of Sensitivity and Cell Death Pathways Mediated by Anti-cancer Drugs Using Three-dimensional Culture System. International Journal of Cancer Research. 14(1). 1–12. 5 indexed citations

12.

Tomita, Kyoko, et al.. (2017). Mixed Lineage Kinase 3 Mediates the Induction of CXCL10 by a STAT1‐Dependent Mechanism During Hepatocyte Lipotoxicity. Journal of Cellular Biochemistry. 118(10). 3249–3259. 43 indexed citations

13.

Higuchi, Hajime, Hidetoshi Sumimoto, Toru Igarashi, et al.. (2012). Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells. Gastric Cancer. 16(1). 100–110. 54 indexed citations

14.

Miyata, Naoteru, Toshifumi Azuma, Shigenari Hozawa, et al.. (2012). Transforming Growth Factor β and Ras/MEK/ERK Signaling Regulate the Expression Level of a Novel Tumor Suppressor Lefty. Pancreas. 41(5). 745–752. 22 indexed citations

15.

Izumiya, Motoko, Ayano Kabashima, Hajime Higuchi, et al.. (2012). Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells.. PubMed. 32(9). 3847–53. 59 indexed citations

16.

Kabashima, Ayano, Hajime Higuchi, Hiromasa Takaishi, et al.. (2009). Side population of pancreatic cancer cells predominates in TGF‐β‐mediated epithelial to mesenchymal transition and invasion. International Journal of Cancer. 124(12). 2771–2779. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact